Characterization of Epstein-Barr virus–infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response
2000; Elsevier BV; Volume: 96; Issue: 13 Linguagem: Inglês
10.1182/blood.v96.13.4055
ISSN1528-0020
AutoresJie Yang, Qian Tao, Ian W. Flinn, Paul G. Murray, Linda Post, H. Ma, Steven Piantadosi, Michael A. Caligiuri, Richard F. Ambinder,
Tópico(s)Eosinophilic Disorders and Syndromes
Referência(s)